resveratrol has been researched along with Arrhythmias, Cardiac in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Baartscheer, A; Bezzina, CR; Bleeker, JC; Coronel, R; Ferdinandusse, S; Guan, K; Houtkooper, RH; IJlst, L; Knottnerus, SJG; Li, W; Luo, X; Mengarelli, I; Portero, VM; Ulbricht, Y; Verkerk, AO; Visser, G; Wanders, RJA; Wijburg, FA; Wüst, RCI | 1 |
| Araújo, EA; Caricati-Neto, A; Errante, PR; Fernandes, MPP; Menezes-Rodrigues, FS; Pires-Oliveira, M; Scorza, CA; Scorza, FA; Silva, MMD; Taha, MO | 1 |
| Bozdogan, O; Eksioglu, D; Erim, F; Firat, T; Kaya, ST; Ozarslan, TO; Taskin, E; Yasar, S | 1 |
| Li, BH; Lu, YZ; Meng, DC; Song, J; Wang, D; Wang, J | 1 |
| Dimova, EY; Fischer-Posovszky, P; Funcke, JB; Kietzmann, T; Wabitsch, M; Zagotta, I | 1 |
| Chen, RH; Gao, L; Guo, K; Li, W; Li, YG; Wang, YP; Xu, QF; Yang, HT; Zhang, PP; Zhou, Q; Zhou, ZW | 1 |
| Mariman, EC; Noben, JP; Renes, J; Rosenow, A; Roumans, N | 1 |
| Fekri, A; Hekmatimoghaddam, S; Klishadi, MS; Safari, F; Shekarforoush, S; Zarei, F | 1 |
| Chen, WP; Hsueh, CH; Hung, LM; Lai, LP; Su, MJ | 1 |
| Chen, C; Huang, S; Pan, Y; Wei, M; Xin, P; Zhu, W | 1 |
| Kong, L; Luo, A; Ma, J; Qian, C; Ren, Z; Wang, C; Wang, X; Wu, Y; Zhang, P; Zhang, S | 1 |
| Chen, JK; Hung, LM; Su, MJ | 1 |
| Li, B; Li, H; Liu, Y; Wang, T; Wang, Z; Yang, B; Zhang, Y | 1 |
| Chen, WP; Hung, LM; Su, MJ | 1 |
14 other study(ies) available for resveratrol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates.
Topics: Action Potentials; Acyl-CoA Dehydrogenase, Long-Chain; Arrhythmias, Cardiac; Cardiac Electrophysiology; Congenital Bone Marrow Failure Syndromes; Epoxy Compounds; Fatty Acids; Humans; Induced Pluripotent Stem Cells; Lipid Metabolism, Inborn Errors; Mitochondria; Mitochondrial Diseases; Muscular Diseases; Myocytes, Cardiac; Oxidation-Reduction; Resveratrol | 2020 |
Cardioprotection stimulated by resveratrol and grape products prevents lethal cardiac arrhythmias in an animal model of ischemia and reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Humans; Ischemia; Male; Rats; Rats, Wistar; Reperfusion; Resveratrol; Stilbenes; Vitis | 2021 |
The protection of resveratrol and its combination with glibenclamide, but not berberine on the diabetic hearts against reperfusion-induced arrhythmias: the role of myocardial K
Topics: Animals; Arrhythmias, Cardiac; Berberine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Glyburide; Heart; Hemodynamics; Male; Myocardial Reperfusion Injury; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Resveratrol | 2019 |
[A study on anti-arrhythmia mechanisms of resveratrol on ischemia/reperfusion in rats by regulating PI3K/Akt signaling pathway].
Topics: Animals; Arrhythmias, Cardiac; Chromones; Male; Morpholines; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Signal Transduction; Stilbenes; Ventricular Function, Left | 2017 |
Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue.
Topics: Adipocytes; Adipose Tissue; AMP-Activated Protein Kinases; Animals; Arrhythmias, Cardiac; Culture Media, Conditioned; DNA; Down-Regulation; Female; Gene Expression Regulation; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Inflammation; Intellectual Disability; Mice; Models, Biological; NF-E2-Related Factor 2; NF-kappa B; Phosphatidylinositol 3-Kinases; Plasminogen Activator Inhibitor 1; Protein Binding; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Sirtuin 1; Stilbenes; Time Factors; Up-Regulation | 2013 |
Resveratrol protects rabbit ventricular myocytes against oxidative stress-induced arrhythmogenic activity and Ca2+ overload.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Cells, Cultured; Heart Ventricles; Male; Myocytes, Cardiac; Oxidative Stress; Rabbits; Reactive Oxygen Species; Resveratrol; Stilbenes | 2013 |
Calorie restriction-induced changes in the secretome of human adipocytes, comparison with resveratrol-induced secretome effects.
Topics: Adipocytes; Adipokines; Adipose Tissue, White; Antioxidants; Arrhythmias, Cardiac; Caloric Restriction; Cells, Cultured; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation; Genetic Diseases, X-Linked; Gigantism; Glucose; Heart Defects, Congenital; Humans; Insulin Resistance; Intellectual Disability; Molecular Sequence Annotation; Obesity; Proteome; Proteomics; Resveratrol; Sirtuin 1; Stilbenes; Tandem Mass Spectrometry | 2014 |
Combined 1,25-Dihydroxy-vitamin D and Resveratrol: A Novel Therapeutic Approach to Ameliorate Ischemia Reperfusion-Induced Myocardial Injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Calcium; Drug Therapy, Combination; Male; Myocardial Infarction; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Resveratrol; RNA, Messenger; Stilbenes; Vitamin D; Vitamins | 2015 |
Piceatannol, a derivative of resveratrol, moderately slows I(Na) inactivation and exerts antiarrhythmic action in ischaemia-reperfused rat hearts.
Topics: Aconitine; Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Caffeine; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Electric Stimulation; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Free Radical Scavengers; Humans; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Resveratrol; Sodium Channel Agonists; Sodium Channel Blockers; Sodium Channels; Stilbenes | 2009 |
Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arrhythmias, Cardiac; Biomarkers; Heart Ventricles; Macrophages; Male; Myocardial Infarction; Myocardium; Nerve Growth Factor; Neurons; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Severity of Illness Index; Stilbenes; Sympathetic Nervous System | 2010 |
Resveratrol attenuates the Na(+)-dependent intracellular Ca(2+) overload by inhibiting H(2)O(2)-induced increase in late sodium current in ventricular myocytes.
Topics: Acetanilides; Animals; Antioxidants; Arrhythmias, Cardiac; Calcium; Diastole; Dose-Response Relationship, Drug; Electrophysiology; Female; Heart Ventricles; Hydrogen Peroxide; Ischemia; Male; Muscle Cells; Patch-Clamp Techniques; Piperazines; Rabbits; Ranolazine; Resveratrol; Sodium; Stilbenes; Temperature; Tetrodotoxin | 2012 |
Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Creatine Kinase; Gene Expression; Heart Rate; L-Lactate Dehydrogenase; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2004 |
Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dose-Response Relationship, Drug; Fruit; Guinea Pigs; Ion Channel Gating; Muscle Cells; Plant Extracts; Rats; Rats, Wistar; Resveratrol; Stilbenes; Survival Rate; Treatment Outcome; Vitis | 2006 |
In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Cardiac; Calcium; Calcium Channels, L-Type; Cells, Cultured; Dose-Response Relationship, Drug; Electrophysiology; Heart Conduction System; In Vitro Techniques; Male; Membrane Potentials; Myocardial Reperfusion Injury; Myocytes, Cardiac; Potassium Channels; Rats; Rats, Sprague-Dawley; Resveratrol; Sodium Channels; Stilbenes; Treatment Outcome; Wine | 2007 |